RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Scott Kuwada to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Scott Kuwada has written about Antibodies, Monoclonal.
Scott Kuwada
Connection Strength
0.532
Antibodies, Monoclonal
  1. Kuwada SK. Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. Curr Opin Mol Ther. 2007 Feb; 9(1):92-8.
    View in: PubMed
    Score: 0.256
  2. Kuwada SK, Scaife CL, Kuang J, Li X, Wong RF, Florell SR, Coffey RJ, Gray PD. Effects of trastuzumab on epidermal growth factor receptor-dependent and -independent human colon cancer cells. Int J Cancer. 2004 Mar 20; 109(2):291-301.
    View in: PubMed
    Score: 0.210
  3. Majer M, Akerley W, Kuwada SK. Oncologists' current opinion on the treatment of colon carcinoma. Anticancer Agents Med Chem. 2007 Sep; 7(5):492-503.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support